Supreme Court agrees to review ‘skinny labeling’ and generic drug access Case is being watched closely for its implications for the availability of cheaper medicines

https://www.statnews.com/pharmalot/2026/01/16/scotus-generics-patents-supreme-court-amarin-hikma/ By Ed SilvermanJan. 16, 2026 Pharmalot Columnist, Senior Writer